Dividends Calendar Earnings Calendar
RUBY

RUBY | Rubius Therapeutics Inc

Rubius Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 1.47B
  • Prev closed: 15.89
  • Open: 16.16
  • High: 17.2
  • Low: 15.9
  • 52 week low: 3.35
  • 52 week high: 17.2
  • Dividends:No Dividends

Next ER: November 8, 2021 



Top Stories (RUBY)

    Company Profile

    Rubius Therapeutics developed our proprietary RED PLATFORM® to generate red blood cells and genetically engineer them into a new class of cellular medicines, called Red Cell Therapeutics™ (RCTs). Our RED PLATFORM harnesses both the unique properties of red blood cells and the creative potential of genetic engineering to deliver on the promise of cellular therapy and transform how diseases are treated.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 9, 2021-0.56 / -0.4887- / -
    May 10, 2021-0.51 / -0.5167- / -
    February 23, 2021-0.5 / -0.526- / -
    November 9, 2020-0.51 / -0.4717- / -
    August 10, 2020-0.47 / -0.49- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Oct 8, 2021 15.96 16.25
    16.50
    15.87
    178.80K -2.62%
    Oct 7, 2021 16.39 16.23
    16.98
    15.75
    321.86K 1.61%
    Oct 6, 2021 16.13 17.22
    17.26
    16.00
    363.18K -7.88%
    Oct 5, 2021 17.51 17.34
    17.73
    16.51
    359.81K 1.57%
    Oct 4, 2021 17.24 17.78
    17.78
    16.86
    305.25K -2.82%
    Oct 1, 2021 17.74 17.93
    18.39
    17.11
    356.35K -0.78%
    Sep 30, 2021 17.88 17.66
    18.42
    17.52
    323.74K 1.59%
    Sep 29, 2021 17.60 18.26
    18.47
    17.40
    228.01K -2.92%
    Sep 28, 2021 18.13 18.93
    19.00
    18.03
    239.00K -4.83%
    Sep 27, 2021 19.05 18.51
    19.49
    18.32
    282.35K 2.42%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:204

    News

    News for (RUBY)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Pablo J Cagnoni

    Talk about Rubius Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 8, 2021 (Same day)

    znga hain newr spg icpt zyne btu iii mwa cara bynd acb 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 33
    HOLD 67
    SELL 0

    Their Official Profiles 

    TwitterLinkedInYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Currency Trading For Dummies
    Buy on Amazon

    Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?